Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane E Sinclair

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Plos Pathogens|October 7, 2021
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosusPengcheng Zhou, Jiali Chen, Jing He, et al.
Frontiers in Cellular and Infection Microbiology|October 1, 2021
Type I Diabetes Mellitus Increases the Cardiovascular Complications of Influenza Virus InfectionJane E Sinclair, Conor J Bloxham, Han Chiu, et al.
The European Respiratory Journal|November 17, 2022
GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infectionCheng Xiang Foo, Stacey Bartlett, Keng Yih Chew, et al.
Immunology|September 15, 2022
Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damageArutha Kulasinghe, Ning Liu, Chin Wee Tan, et al.
Nature Microbiology|October 31, 2024
Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte functionJane E Sinclair, Courtney Vedelago, Feargal J Ryan, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Plos Pathogens|October 7, 2021
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosusPengcheng Zhou, Jiali Chen, Jing He, et al.
Frontiers in Cellular and Infection Microbiology|October 1, 2021
Type I Diabetes Mellitus Increases the Cardiovascular Complications of Influenza Virus InfectionJane E Sinclair, Conor J Bloxham, Han Chiu, et al.
The European Respiratory Journal|November 17, 2022
GPR183 antagonism reduces macrophage infiltration in influenza and SARS-CoV-2 infectionCheng Xiang Foo, Stacey Bartlett, Keng Yih Chew, et al.
Immunology|September 15, 2022
Transcriptomic profiling of cardiac tissues from SARS-CoV-2 patients identifies DNA damageArutha Kulasinghe, Ning Liu, Chin Wee Tan, et al.
Nature Microbiology|October 31, 2024
Post-acute sequelae of SARS-CoV-2 cardiovascular symptoms are associated with trace-level cytokines that affect cardiomyocyte functionJane E Sinclair, Courtney Vedelago, Feargal J Ryan, et al.
Pageof 2